vimarsana.com
Home
Live Updates
Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure
Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure
Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure® Blood Test Can Identify Patients at High Risk of Significant Cognitive Decline Due to Alzheimer's Disease
—Data from 479-Patient Study Confirms Strong Prognostic Utility of AlzoSure® Predict for Identifying Whether or Not Individuals Will Experience a Significant...
Related Keywords
Australia ,
Milan ,
Lombardia ,
Italy ,
Amsterdam ,
Noord Holland ,
Netherlands ,
Australian ,
Christopher Fowler ,
Leander Van Neste ,
Daniela Uberti ,
Simona Piccirella ,
Paul Kinnon ,
Jurgen Fripp ,
Sam Agus ,
Barbara Lindheim ,
Jamesd Doecke ,
University Of Brescia ,
Drug Research ,
Alzheimer Association International Conference ,
Us Food Drug Administration ,
Patient Study Confirms Strong Prognostic Utility ,
Identifying Whether ,
Not Individuals Will Experience ,
Significant Cognitive Decline ,
Year Timeframe ,
Will Develop ,
Predict Can Facilitate Access ,
Effective Treatment ,
At Risk Patients ,
Help Accelerate New Drug Research ,
Diadem Anticipates ,
Predict Will Be Commercially Available ,
Association International ,
Australian Imaging ,
Breakthrough Device ,
Drug Administration ,
Colinl Masters ,
Diadem Spa ,